claudin-11 Antibodies

Santa Cruz Biotechnology delivers a wide array of claudin-11 monoclonal antibodies for research focused on understanding this critical tight junction protein. claudin-11 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Claudin-11 is essential for the formation of tight junctions in the central nervous system and plays a significant role in maintaining the integrity of the blood-brain barrier. Its proper function is crucial for neuronal signaling and overall brain health, making claudin-11 a key target in studies related to neurodegenerative diseases and brain injuries. Understanding the mechanisms involving claudin-11 can provide insights into therapeutic strategies for various neurological disorders. Researchers can explore tight junction dynamics in both normal physiological conditions and disease states using specific detection methods. Investigating claudin-11 expression patterns helps advance knowledge about blood-brain barrier regulation and potential therapeutic interventions. Current research highlights claudin-11's importance in maintaining central nervous system homeostasis and its potential as a therapeutic target. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of claudin-11's role in neurological health and disease.